Avantor, Inc. Share-based Payment Arrangement, Expense
Avantor, Inc. (AVTR) reported Share-based Payment Arrangement, Expense of $8.60 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-04-29
- Avantor, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $8.60M, a 30.65% decline year-over-year.
- Avantor, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $11.30M, a 1.80% increase year-over-year.
- Avantor, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $7.30M, a 38.66% decline year-over-year.
- Avantor, Inc. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $15.50M, a 39.64% increase year-over-year.
- Avantor, Inc. share-based payment arrangement, expense for fiscal 2025 was $46.40M, a 0.85% decline from fiscal 2024.
- Avantor, Inc. share-based payment arrangement, expense for fiscal 2024 was $46.80M, a 15.56% increase from fiscal 2023.
- Avantor, Inc. share-based payment arrangement, expense for fiscal 2023 was $40.50M, a 11.57% decline from fiscal 2022.
- Avantor, Inc. share-based payment arrangement, expense for fiscal 2022 was $45.80M, a 9.66% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $8.60M 10-Q · filed 2026-04-29 | $19.90M derived: sum of 2 quarters · filed 2026-04-29 | $27.20M derived: sum of 3 quarters · filed 2026-04-29 | $42.70M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $18.60M derived: sum of 2 quarters · filed 2026-02-11 | $34.10M derived: sum of 3 quarters · filed 2026-02-11 | $46.40M 10-K · filed 2026-02-11 |
| 2025-09-30 | $7.30M 10-Q · filed 2025-10-29 | $22.80M derived: sum of 2 quarters · filed 2025-10-29 | $35.10M 10-Q · filed 2025-10-29 | $46.30M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $15.50M 10-Q · filed 2025-08-01 | $27.90M 10-Q · filed 2025-08-01 | $39.00M derived: sum of 3 quarters · filed 2026-04-29 | $50.90M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $12.40M 10-Q · filed 2026-04-29 | $23.50M derived: sum of 2 quarters · filed 2026-04-29 | $35.40M derived: sum of 3 quarters · filed 2026-04-29 | $46.50M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $11.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $23.00M derived: sum of 2 quarters · filed 2026-02-11 | $34.10M derived: sum of 3 quarters · filed 2026-02-11 | $46.80M 10-K · filed 2026-02-11 |
| 2024-09-30 | $11.90M 10-Q · filed 2025-10-29 | $23.00M derived: sum of 2 quarters · filed 2025-10-29 | $35.70M 10-Q · filed 2025-10-29 | $44.50M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $11.10M 10-Q · filed 2025-08-01 | $23.80M 10-Q · filed 2025-08-01 | $32.60M derived: sum of 3 quarters · filed 2026-02-11 | $42.40M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $12.70M 10-Q · filed 2025-04-25 | $21.50M derived: sum of 2 quarters · filed 2026-02-11 | $31.30M derived: sum of 3 quarters · filed 2026-02-11 | $40.50M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $18.60M derived: sum of 2 quarters · filed 2026-02-11 | $27.80M derived: sum of 3 quarters · filed 2026-02-11 | $40.50M 10-K · filed 2026-02-11 |
| 2023-09-30 | $9.80M 10-Q · filed 2024-10-25 | $19.00M derived: sum of 2 quarters · filed 2024-10-25 | $31.70M 10-Q · filed 2024-10-25 | $41.70M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $9.20M 10-Q · filed 2024-07-26 | $21.90M 10-Q · filed 2024-07-26 | $31.90M derived: sum of 3 quarters · filed 2025-02-07 | $44.00M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $12.70M 10-Q · filed 2024-04-26 | $22.70M derived: sum of 2 quarters · filed 2025-02-07 | $34.80M derived: sum of 3 quarters · filed 2025-02-07 | $47.80M derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $22.10M derived: sum of 2 quarters · filed 2025-02-07 | $35.10M derived: sum of 3 quarters · filed 2025-02-07 | $45.80M 10-K · filed 2025-02-07 |
| 2022-09-30 | $12.10M 10-Q · filed 2023-10-27 | $25.10M derived: sum of 2 quarters · filed 2023-10-27 | $35.80M 10-Q · filed 2023-10-27 | $49.50M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $13.00M 10-Q · filed 2023-07-28 | $23.70M 10-Q · filed 2023-07-28 | $37.40M derived: sum of 3 quarters · filed 2024-02-14 | $50.90M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $10.70M 10-Q · filed 2023-04-28 | $24.40M derived: sum of 2 quarters · filed 2024-02-14 | $37.90M derived: sum of 3 quarters · filed 2024-02-14 | $50.10M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $13.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $27.20M derived: sum of 2 quarters · filed 2024-02-14 | $39.40M derived: sum of 3 quarters · filed 2024-02-14 | $50.70M 10-K · filed 2024-02-14 |
| 2021-09-30 | $13.50M 10-Q · filed 2022-10-28 | $25.70M derived: sum of 2 quarters · filed 2022-10-28 | $37.00M 10-Q · filed 2022-10-28 | $49.80M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $12.20M 10-Q · filed 2022-07-29 | $23.60M 10-Q · filed 2022-07-29 | $36.30M derived: sum of 3 quarters · filed 2023-02-14 | $47.70M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $11.40M 10-Q · filed 2022-04-29 | $24.10M derived: sum of 2 quarters · filed 2023-02-14 | $35.50M derived: sum of 3 quarters · filed 2023-02-14 | $47.10M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $12.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $24.10M derived: sum of 2 quarters · filed 2023-02-14 | $35.70M derived: sum of 3 quarters · filed 2023-02-14 | $44.10M 10-K · filed 2023-02-14 |
| 2020-09-30 | $11.40M 10-Q · filed 2021-10-29 | $23.00M derived: sum of 2 quarters · filed 2021-10-29 | $31.40M 10-Q · filed 2021-10-29 | $41.90M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $11.60M 10-Q · filed 2021-07-30 | $20.00M 10-Q · filed 2021-07-30 | $30.50M derived: sum of 3 quarters · filed 2022-02-11 | $32.20M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $8.40M 10-Q · filed 2021-04-28 | $18.90M derived: sum of 2 quarters · filed 2022-02-11 | $20.60M derived: sum of 3 quarters · filed 2022-02-11 | $71.30M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $10.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $12.20M derived: sum of 2 quarters · filed 2022-02-11 | $62.90M derived: sum of 3 quarters · filed 2022-02-11 | $67.90M 10-K · filed 2022-02-11 |
| 2019-09-30 | $1.70M 10-Q · filed 2020-10-27 | $52.40M derived: sum of 2 quarters · filed 2020-10-27 | $57.40M 10-Q · filed 2020-10-27 | $61.10M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $50.70M 10-Q · filed 2020-07-29 | $55.70M 10-Q · filed 2020-07-29 | $59.40M derived: sum of 3 quarters · filed 2021-02-16 | $65.20M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $4.80M 10-Q · filed 2020-04-29 | $8.70M derived: sum of 2 quarters · filed 2021-02-16 | $14.50M derived: sum of 3 quarters · filed 2021-02-16 | $18.70M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $9.70M derived: sum of 2 quarters · filed 2021-02-16 | $13.90M derived: sum of 3 quarters · filed 2021-02-16 | $18.40M 10-K · filed 2021-02-16 |
| 2018-09-30 | $5.80M 10-Q · filed 2019-11-05 | $10.00M derived: sum of 2 quarters · filed 2019-11-05 | $14.50M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $4.20M 10-Q · filed 2019-08-06 | $8.70M 10-Q · filed 2019-08-06 | ||
| 2017-12-31 | $48.20M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |